Treatment with R-MegaCHOP and early rescue with R-IFE and autologous stem cells transplant (ASCT) according response measured by positron emission tomography (PET) in patients with diffuse large B-cell lymphoma (DLBCL) with severe prognosis.
ESTADO CLÍNICO
En marcha
FASE/S DEL ENSAYO
Fase IV
PATOLOGÍA
Linfoma no Hodgkin, Terapia celular y T-CARs, Trasplante de progenitores hematopoyéticos, Linfoma
FECHA DE APERTURA
Enero, 2007
FECHA DE CIERRE
,
CRITERIOS DE INCLUSIÓN
Diffuse Large B-Cell Lymphoma (DLBCL)
CRITERIOS DE EXCLUSIÓN
No especificado
DESCRIPCIÓN
The principal end point is the valoration of the event free survival (EFS) three years later
PALABRAS CLAVE
autologous, autologous transplant, cd20, dlbcl, lymphoma, stem cell
